The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Pharmacyclics

  • PCYC
  • NASDAQ
  • Consumer Products
  • Latest 90.04
  • Currency US$
  • Change -1.82
  • Percent Change -1.981 %
  • Volume 1,493,569
  • Wed Apr 16, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
  • Open 92.42
  • Previous Close 91.86
  • High 94.36
  • Low 88.70
  • Bidx0 0.0000
  • Askx0 0.0000
  • 52-week High02/21 154.89
  • 52-week Low04/16 71.85
  • Beta 1.259
  • Market Cap 6,636.85M
  • EPS 0.80
  • P/E 112.55
  • Forward P/E
  • PEG
  • Annual Dividend 0.0000
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $260,170,000
  • Earnings $67,010,000
  • Return on Equity 11.59%

Cash Flow

  • Cash Flow --
  • Cash $623,950,000
  • Current Ratio 8.45

12 months ended Dec 31, 2013.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $768,750,000
  • Liabilities $141,120,000
  • Liabilities-to-Equity Ratio 0.22

Price Ratios

  • Price to Sales 25.51
  • Price to Book 10.57
  • Price to Cash Flow n/a

Event Calendar

Event Last   Next  
Earnings Feb 20 $0.77 May 7 $0.13
Surprises Feb 20 6.49% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Apr 17, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

Pharmacyclics Inc. is a pharmaceutical company developing products to improve upon therapeutic approaches to cancer, atherosclerosis and retinal disease. The company's products are ring-shaped small molecules called texaphyrins. These patented agents are derived from Pharmacyclics' versatile technology platform for designing and synthesizing energy-potentiating drugs. The texaphyrins localize in cancer cells, atherosclerotic plaque and neovasculature, where they can be activated by forms of energy, including X-rays and light to reduce diseased tissue.

Related Securities
Symbol Type Latest % Chg

Officers

  • Robert W. Duggan Chairman of the Board & C.E.O
  • Manmeet Soni Chief Financial Officer
  • Company Type: n/a
  • Company Status: n/a
  • Full-time Employees: n/a
  • Incorporation: United States,
    n/a
  • Top 1000 Ranking: Profit: n/a
    Revenue: n/a
    Assets: n/a

Head Office

PHARMACYCLICS INC 995 E ARQUE
SUNNYVALE, CA
94085-4

Phone: (408)-774-0330
Fax: (408)-7740340


www.pharmacyclics.com

Ideas & Discussion

Live Discussion of PCYC on StockTwits